Concepedia

James B. Rottman

JB

Statistics

Publications

63

Citations

10.8K

H-Index

41

Active since

1991

Affiliations

Amgen (United States)(Current)

Millennium Engineering and Integration (United States)

North Carolina State University

KalVista Pharmaceuticals (United States)

Harvard University

James B. Rottman is an author at Amgen (United States) specializing in immunology, life sciences, and inflammation.

ORCID

Publications per year

1991–2024

63

Publications

63

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

Suofu Qin, James B. Rottman, Patricia N. Myers et al. · Journal of Clinical Investigation · 1998 · 1.4K citations · Full text

, , +13

CCR5 <sup>+</sup> and CXCR3 <sup>+</sup> T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions

Konstantin Balashov, James B. Rottman, Howard L. Weiner et al. · Proceedings of the National Academy of Sciences · 1999 · 847 citations · Full text

, , +17

The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells

James J. Campbell, Guttorm Haraldsen, Junliang Pan et al. · Nature · 1999 · 841 citations

, , +16

CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro

Lijun Wu, William A. Paxton, Nasim Kassam et al. · The Journal of Experimental Medicine · 1997 · 710 citations · Full text

, , +17

Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells

Ying Sun, Qiu Meng, James B. Rottman et al. · European Journal of Immunology · 1997 · 425 citations

, , +16

1–5 of 63